GERMAN drugmaker Fresenius Kabi has started voluntary recall of two batches of a cancer drug shipped to the US made by its Indian subsidiary Fresenius Kabi Oncology Ltd after it found cross contamination.

The drug sold as anastrozole tablets is used to treat breast cancer and is sold in the US through Fresenius Kabi